Results 41 to 50 of about 971,475 (405)

Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer.

Annals of Oncology, 2016
BACKGROUND Lung cancer is the leading cause of cancer deaths, having caused an estimated 1.6 million deaths worldwide in 2012 [Ferlay J, Soerjomataram I, Dikshit R et al.
S. Schild, E. Vokes
semanticscholar   +1 more source

Combined modality therapy of rectal cancers

Annals of Oncology, 1999
Rectal cancer accounts for about 10% of new cancer cases each year. It strikes men and women at nearly the same rate, generally in the range of 50-80 years of age, with rising incidence with age. Despite simple screening procedures rectal cancer is often advanced when discovered.
Hrvoje Šobat, Antonio Juretić, Mirko Samija   +2 more
openaire   +4 more sources

External radiotherapy of thyroid cancer [PDF]

, 2001
Differentiated thyroid cancer comprises papillary, mixed papillary-follicular and follicular adenocarcinomas. They are mostly hormone-sensitive and respond to thyroid-stimulating hormone (TSH) suppression. The standard treatment is total thyroidectomy. I-
Dühmke, Eckhart, Pollinger, B.
core   +1 more source

Recognizing early MRI signs (or their absence) is crucial in diagnosing metachromatic leukodystrophy

Annals of Clinical and Translational Neurology, Volume 9, Issue 12, Page 1999-2009, December 2022., 2022
Abstract Objectives Metachromatic leukodystrophy (MLD) has characteristic white matter (WM) changes on brain MRI, which often trigger biochemical and genetic confirmation of the diagnosis. In early or pre‐symptomatic disease stages, these typical MRI changes might be absent, hampering early diagnosis.
Daphne H. Schoenmakers, Shanice Beerepoot, Ingeborg Krägeloh‐Mann, Saskia Elgün, Benjamin Bender, Marjo S. van der Knaap, Nicole I. Wolf, Samuel Groeschel   +7 more
wiley   +1 more source

Efficacy indicators of four methods in outpatient addiction treatment [PDF]

, 2017
Background In Portugal, as far as we know, there are no recent studies that evaluated the comparative efficacy of therapeutic modalities in addiction problems by reference to a holistic and psychosocial model of effectiveness.
FERROS, LÍGIA, JONGENELEN, INÊS, MOURA, ANDREIA DE, NEGREIROS, JORGE, PINTO, RICARDO   +4 more
core   +3 more sources

Improved survival with combined modality therapy in the modern era for primary mediastinal B‐cell lymphoma

American journal of hematology/oncology, 2016
Primary mediastinal B‐cell lymphoma (PMBCL) is an uncommon lymphoma for which existing data is limited. We utilized the National Cancer Database (NCDB) to evaluate PMBCL and the impact of radiotherapy (RT) on outcomes in the years following FDA approval ...
M. Jackson, C. Rusthoven, B. Jones, M. Kamdar, R. Rabinovitch   +4 more
semanticscholar   +1 more source

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial

TH Open, 2022
Background The MARINER trial evaluated whether postdischarge thromboprophylaxis with rivaroxaban could reduce the primary outcome of symptomatic venous thromboembolism (VTE) or VTE-related death in acutely ill medical patients at risk for VTE.
Alex C. Spyropoulos, Mark Goldin, Walter Ageno, Gregory W. Albers, C. Gregory Elliott, William R. Hiatt, Jonathan L. Halperin, Gregory Maynard, P. Gabriel Steg, Jeffrey I. Weitz, Theodore E. Spiro, Wentao Lu, Jessica Marsigliano, Gary E. Raskob, Elliot S. Barnathan   +14 more
doaj   +1 more source

Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit? [PDF]

, 2011
Background Nasopharyngeal carcinoma (NPC) with lung metastasis alone has been reported as a relatively favorable prognostic group, and combined modality treatment might be indicated for selected cases. However, the prognostic factors determining survival
A Fandi, A Haro, A Jemal, A Khanfir, A Khanfir, AR Razak, AT Chan, CT Wang, DT Chua, EP Hui, F Chen, Fang-Yun Xie, FB Geara, FM Fang, H Winter, HA Wolff, J Ma, J Wee, LC Cheng, Li-Ru He, PM Teo, RK Ngan, RN Younes, S Shiono, S Shiono, SA Leibel, SS Leong, T Gokce, WH Kwan, WI Wei, WT Ng, Xun Cao, YK Ong, You-Fang Chen, Zhe-Sheng Wen   +34 more
core   +3 more sources

Locally advanced cervical cancer: Preliminary results of the prospective randomized study [PDF]

Archive of Oncology, 2003
Background: The aim of this study is to show preliminary results of the randomized study that has been conducted among patients with advanced cervical cancer managed by loco-regional radiotherapy alone or combined treatment (radiotherapy with ...
Stanković Vesna V., Marjanov Ivanka, Čikarić Slobodan, Gržetić Ljubomir, Čolaković Slobodanka, Raković Brankica   +5 more
doaj   +1 more source

Lung cancer: Combined modality therapy in NSCLC

Annals of Oncology, 2000
Combined modality treatment has 'come out of age' and increasingly represents standard of care for a rapidly growing number of patients in locally advanced stages of NSCLC. Modern progress of treatment techniques as well as possibilities for supportive interventions will lead to lesser treatment toxicities, better patient's compliance to treatment ...
Sönke Korfee, Wilfried Eberhardt, Stephan Bildat   +2 more
openaire   +3 more sources